Friday, February 17, 2017

BRIEF-Myriad’s provides data on prostate cancer test

* Myriad’s Prolaris® Test significantly improves the risk

classification for one third of men diagnosed with localized

prostate cancer

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)